Clinical Trials Directory

Trials / Unknown

UnknownNCT01232114

Safety Study of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional Dyspepsia

Phase 2 Study of of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional Dyspepsia

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Hunan University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Functional dyspepsia (FD) is a common functional gastrointestinal disorder and is steadily becoming a public health problem.Simotang is a classical formula that has been used to treat gastrointestinal disorders for hundreds of years \[9\] and was approved as an oral liquid drug by the Chinese National Food and Drug Administration in the 1980s.In this study,patients with functional dyspepsia were divided according to the inclusive criteria into treatment group and control group randomly, who were given Simo decoction or Domperidone tablets for 14 days。And then the gastric emptying, Symptoms in plasma were observed before and after treatment in mult-center.

Conditions

Timeline

Start date
2010-10-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2010-11-02
Last updated
2010-11-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01232114. Inclusion in this directory is not an endorsement.

Safety Study of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional Dyspepsia (NCT01232114) · Clinical Trials Directory